Literature DB >> 3266291

Synthetic peptide inhibitors of complement serine proteases--I. Identification of functionally equivalent protease inhibitor sequences in serpins and inhibition of C1s and D.

G I Glover1, C S Schasteen, W S Liu, R P Levine.   

Abstract

Sequence homology comparisons between serum serine protease inhibitors led to the prediction that the C-terminal sequences are functionally equivalent and represent an essential protease binding domain. Inhibition of complement serine protease D cleavage of factor B and of C1s cleavage of C4 by synthetic peptides containing sequences from the C-termini of three serum serine protease inhibitors supports this prediction. These functionally equivalent peptides represent a new class of inhibitors of D and C1s as well as other serum serine proteases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3266291     DOI: 10.1016/0161-5890(88)90040-5

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  4 in total

1.  Identification of a serpin-enzyme complex receptor on human hepatoma cells and human monocytes.

Authors:  D H Perlmutter; G I Glover; M Rivetna; C S Schasteen; R J Fallon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

Review 2.  Structure, functions, and evolution of the third complement component and viral molecular mimicry.

Authors:  A Sahu; J O Sunyer; W T Moore; M R Sarrias; A M Soulika; J D Lambris
Journal:  Immunol Res       Date:  1998       Impact factor: 4.505

3.  Complement activation by whole endotoxin is blocked by a monoclonal antibody to factor B.

Authors:  C W Clardy
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

4.  Alpha 1-antitrypsin deficiency, complement activation, and chronic liver disease.

Authors:  E T Littleton; L Bevis; L J Hansen; M Peakman; A P Mowat; G Mieli-Vergani; D Vergani
Journal:  J Clin Pathol       Date:  1991-10       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.